Insider filing · TEVA
Evan Lippman
EVP, Business Development
profile →
Teva Pharmaceutical Industries Limited
TEVA · Healthcare · 60 filings in 24 months
ticker →
Evan Lippman sold $680K of Teva Pharmaceutical Industries Limited (TEVA)
Executed Aug 17, disclosed Aug 19, 2 days later.
Value, as filed
$680K
18,600 sh × $36.57
Executed
Aug 17
the trade date, as filed
Disclosed
Aug 19
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ELEvan Lippman (EVP, Business Development) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Teva Pharmaceutical Industries Limited (TEVA). The largest single filing was $1.5M of TEVA (41,658 sh across 2 lots, as filed), executed May 14.
The name
TEVAHealthcare · Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Evan Lippman in TEVA
TEVASALE
Teva Pharmaceutical Industries Limited
$1.5M41,658 sh across 2 lots
Exec May 14
Filed May 18 · 5:30 PM ET